| Lyka Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500259 |
NSE Symbol : LYKALABS |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE933A01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 24.19 |
Market Cap(₹Cr) : 288.64 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 42.31 | 28.03 | 30.73 | 32.97 | 29.18 | 30.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 42.31 | 28.03 | 30.73 | 32.97 | 29.18 | 30.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.42 | 0.51 | 1.37 | 1.21 | 0.77 | 0.82 |
| Total Income | 42.73 | 28.54 | 32.09 | 34.19 | 29.95 | 31.34 |
| Total Expenditure | 37.72 | 55.53 | 28.83 | 36.12 | 25.82 | 27.22 |
| PBIDT | 5.01 | -26.99 | 3.26 | -1.94 | 4.13 | 4.12 |
| Interest | 1.01 | 0.87 | 0.82 | 0.79 | 0.85 | 0.52 |
| PBDT | 4.00 | -27.86 | 2.45 | -2.73 | 3.28 | 3.60 |
| Depreciation | 2.01 | 2.04 | 2.15 | 2.07 | 2.11 | 1.42 |
| Tax | 0.00 | 0.34 | 0.00 | 0.18 | 0.31 | 0.68 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.11 | -0.47 | 0.00 | -1.35 | 0.05 | 0.28 |
| Reported Profit After Tax | 2.10 | -29.77 | 0.29 | -3.63 | 0.81 | 1.23 |
| Extra-ordinary Items | 0.00 | -22.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.10 | -7.02 | 0.29 | -3.63 | 0.81 | 1.23 |
| EPS (Unit Curr.) | 0.58 | -8.24 | 0.08 | -1.02 | 0.22 | 0.36 |
| EPS (Adj) (Unit Curr.) | 0.58 | -8.24 | 0.08 | -1.02 | 0.22 | 0.36 |
| Calculated EPS (Unit Curr.) | 0.58 | -8.24 | 0.08 | -1.02 | 0.22 | 0.34 |
| Calculated EPS (Adj) (Unit Curr.) | 0.58 | -8.24 | 0.08 | -1.02 | 0.22 | 0.34 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.32 | -32.94 | 0.33 | -4.06 | 0.90 | 1.38 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.32 | -32.94 | 0.33 | -4.06 | 0.90 | 1.38 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 36.15 | 36.15 | 35.69 | 35.69 | 36.15 | 35.69 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.84 | -96.29 | 10.61 | -5.88 | 14.15 | 13.50 |
| PBDTM(%) | 9.45 | -99.39 | 7.97 | -8.28 | 11.24 | 11.80 |
| PATM(%) | 4.96 | -106.21 | 0.94 | -11.01 | 2.78 | 4.03 |
